Basic Information
Bellerophon Therapeutics is a clinical-stage biotherapeutics company dedicated to developing innovative products that combine novel drugs and devices for the treatment of cardiopulmonary and heart diseases. Our mission is to develop molecular systems through innovative research, conducting in-depth studies on molecules to treat diseases with significant clinical needs.
Bellerophon Therapeutics, Inc.
NewJersey,United States of America
15~50 people
January 01, 2009
--

